Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies  Pankaj.

Slides:



Advertisements
Similar presentations
Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
Advertisements

Identification and functions of pattern-recognition receptors
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Transcriptional activation by MLL fusion proteins in leukemogenesis
Uncontrolled Wnt signaling causes leukemia
Nat. Rev. Rheumatol. doi: /nrrheum
Another Notch on the belt
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
You have identified a novel cytoplasmic protein
Identification and functions of pattern-recognition receptors
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
Pancreatic β cells: Responding to the matrix
Volume 79, Issue 9, Pages (May 2011)
Acid Test: Lipid Antigens Get into the Groove
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Erythropoietins: A common mechanism of action
Velizar Shivarov, Lars Bullinger  Experimental Hematology 
On the TRAIL to Overcome BRAF-Inhibitor Resistance
Ya-Huei Kuo, Jing Qi, Guerry J. Cook  Experimental Hematology 
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders  Caiyi Wang, Zheng Fang, Zesen Zhu, Jing.
Ashok Kumar Jayavelu, Jennifer N. Moloney, Frank-D. Böhmer, Thomas G
Alison A. Laing, Christine J. Harrison, Brenda E. S
Quiescence regulators for hematopoietic stem cell
Induced pluripotent stem cell modeling of malignant hematopoiesis
Regulation of Iron Uptake by IRT1: Endocytosis Pulls the Trigger
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia  Michelle L. Churchman, Charles G. Mullighan 
Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures  Igor I. Slukvin,
Pathogenesis of myeloproliferative neoplasms
Experimental Hematology
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Arati Khanna-Gupta  Experimental Hematology 
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
A New FOXO Pathway Required for Leukemogenesis
Rejuvenating Exhausted T Cells during Chronic Viral Infection
Negative Feedback Mechanisms and Their Roles during Pattern Formation
Rik van der Kant, Lawrence S.B. Goldstein  Developmental Cell 
Peter Karagiannis, Shinya Yamanaka, Megumu K. Saito 
SRC and STAT Pathways Journal of Thoracic Oncology
Raquel Espín-Palazón, David Traver  Experimental Hematology 
Inside This Issue Experimental Hematology
Endocytic trafficking of CFTR in health and disease
Hedgehog signalling: off the shelf modulation
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Masaru Katoh  Journal of Investigative Dermatology 
Tumor necrosis factor α in the onset and progression of leukemia
Pharmacological activation of wild-type p53 in the therapy of leukemia
Volume 88, Issue 4, Pages (November 2015)
Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm  Jia Zhu, Richard.
Synaptic plasticity: Rush hour traffic in the AMPA lanes
Ethylene Prunes Translation
Kinase signaling and targeted therapy for primary myelofibrosis
Janna Krueger, Christopher E. Rudd  Immunity 
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Progress in Cutaneous Cancer Research1
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Jinhua Tang, Na Liu, Shougang Zhuang  Kidney International 
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
Volume 71, Issue 3, Pages (February 2007)
Notch Ligand Ubiquitylation: What Is It Good For?
Erratum Experimental Hematology
Markus Böhm, Thomas A. Luger, Desmond J
Stem cell biology and the plasticity polemic
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Another niche for Notch
Novel pharmacological strategies to treat cystic fibrosis
Neha Vaid, Anca Macovei, Narendra Tuteja  Molecular Plant 
Presentation transcript:

Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies  Pankaj Dwivedi, Kenneth D. Greis  Experimental Hematology  Volume 46, Pages 9-20 (February 2017) DOI: 10.1016/j.exphem.2016.10.008 Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Experimental Hematology 2017 46, 9-20DOI: (10.1016/j.exphem.2016.10.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 1 Topography of G-CSFR depicting various structural domains and the mutations associated with specific domains leading to neutropenia and leukemia. Experimental Hematology 2017 46, 9-20DOI: (10.1016/j.exphem.2016.10.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 2 Major downstream signaling pathways of normal and variant G-CSFR. (A) In normal G-CSFR, the major pathways activated downstream of the receptor are JAK/STAT, PI3K/AKT, and MAPK/ERK, whereas SOCS acts as negative regulator of the overall signaling. (B) G-CSFR with a mutated extracellular receptor leads to disruption of G-CSF binding, causing the cessation of downstream signaling. (C) Proximally mutated receptor becomes auto-activated and facilitates constitutive activation of the downstream pathways even in the absence of ligand. (D) Several truncations in the cytoplasmic domains of G-CSFR lead to hyperresponse to G-CSF and uncontrolled signaling downstream of the receptor on ligand binding. Experimental Hematology 2017 46, 9-20DOI: (10.1016/j.exphem.2016.10.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 3 G-CSFR routing and recycling. (A) In the wild-type receptor, G-CSF-induced activation leads to receptor internalization and endosome formation. Although the receptor is internalized, downstream signaling continues. After this point, the receptor has two modes to move forward: it either is dephosphorylated and deubiquitinated, further processed in endoplasmic reticulum and Golgi, and recycled to plasma membrane, or it transitions into the late endosome and is degraded by the lysosomal pathway. (B) In membrane proximally mutated receptors, it is postulated that the recycling rate is increased with rapid processing through endoplasmic reticulum and Golgi. (C) In cases where the mutation results in intracellular domain truncation, the receptor recycling/degradation process is disrupted because of loss of the motif required for endocytic signaling. This leads to increased receptor expression on the plasma membrane and sustained downstream signaling. Experimental Hematology 2017 46, 9-20DOI: (10.1016/j.exphem.2016.10.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 4 Possible roles played by kinases and phosphatases in overall G-CSFR signaling and their decisive effects on myeloid cell production and neutrophils. Experimental Hematology 2017 46, 9-20DOI: (10.1016/j.exphem.2016.10.008) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions